Regulatory News

The FDA is embarking on an innovative journey to enhance communication with the import community by unveiling new, streamlined channels of information dissemination. In a significant shift, the FDA’s Office of Import Operations is transitioning away from the traditional Cargo Systems Messaging Service (CSMS) utilized by CBP, opting instead for a more direct and efficient approach. Through the implementation of an automated notification system, the FDA aims to foster clearer, more immediate communication with stakeholders. This proactive step not only underscores the FDA's commitment to transparency and responsiveness but also reflects a forward-thinking approach that is poised to strengthen collaboration and improve the overall import process.

The United States has announced a significant policy shift regarding tariffs on Chinese imports, aimed at addressing the fentanyl crisis. Effective November 10, 2025, the U.S. will reduce tariffs by 10 percentage points and extend the suspension of heightened reciprocal tariffs until November 10, 2026. Additionally, certain Section 301 tariff exclusions will be extended until November 10, 2026. This approach reflects the ongoing efforts to balance trade relations while addressing public health concerns.